Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Bengtsson

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 11, 2005
Emulation of quantum mechanical billiards by electrical resonance circuitsOlof Bengtsson, Johan Larsson, Karl-Fredrik Berggren
Statistical Methods in Medical Research|July 30, 2020
Adjusted win ratio with stratification: Calculation methods and interpretationSamvel B Gasparyan, Folke Folkvaljon, Olof Bengtsson, et al.
Acta Oncologica (Stockholm, Sweden)|October 30, 2009
The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancerJohanna Sjöström-Mattson, Kristina Von Boguslawski, Nils-Olof Bengtsson, et al.
Journal of Biopharmaceutical Statistics|September 23, 2021
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trialsSamvel B Gasparyan, Elaine K Kowalewski, Folke Folkvaljon, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2006
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancerKenneth Villman, Johanna Sjöström, Reino Heikkilä, et al.
Journal of the National Cancer Institute|November 3, 2005
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trialBo Nordenskjöld, Johan Rosell, Lars-Erik Rutqvist, et al.
Breast Cancer Research and Treatment|March 5, 2013
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-upJohan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, et al.
Acta Oncologica (Stockholm, Sweden)|January 13, 2017
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifenJohan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 17, 2024
Literature review: potential non-thermal molecular effects of external radiofrequency electromagnetic fields on cancerAnna Dieper, Stephan Scheidegger, Rudolf M Füchslin, et al.
Breast (Edinburgh, Scotland)|July 30, 2023
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapyAnna Nordenskjöld, Helena Fohlin, Johan Rosell, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 11, 2005
Emulation of quantum mechanical billiards by electrical resonance circuitsOlof Bengtsson, Johan Larsson, Karl-Fredrik Berggren
Statistical Methods in Medical Research|July 30, 2020
Adjusted win ratio with stratification: Calculation methods and interpretationSamvel B Gasparyan, Folke Folkvaljon, Olof Bengtsson, et al.
Acta Oncologica (Stockholm, Sweden)|October 30, 2009
The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancerJohanna Sjöström-Mattson, Kristina Von Boguslawski, Nils-Olof Bengtsson, et al.
Journal of Biopharmaceutical Statistics|September 23, 2021
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trialsSamvel B Gasparyan, Elaine K Kowalewski, Folke Folkvaljon, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2006
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancerKenneth Villman, Johanna Sjöström, Reino Heikkilä, et al.
Journal of the National Cancer Institute|November 3, 2005
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trialBo Nordenskjöld, Johan Rosell, Lars-Erik Rutqvist, et al.
Breast Cancer Research and Treatment|March 5, 2013
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-upJohan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, et al.
Acta Oncologica (Stockholm, Sweden)|January 13, 2017
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifenJohan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 17, 2024
Literature review: potential non-thermal molecular effects of external radiofrequency electromagnetic fields on cancerAnna Dieper, Stephan Scheidegger, Rudolf M Füchslin, et al.
Breast (Edinburgh, Scotland)|July 30, 2023
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapyAnna Nordenskjöld, Helena Fohlin, Johan Rosell, et al.
Pageof 8